1Sowers J R.Obesity as a cardiovascular risk factor[J].Am J Med,2003,115(Suppl 8A):37S-41S.
2Kambham N,Markowitz G S,Valeri A M,et al.Obesity-related glomerulopathy:an emerging epidemic[J].Kidney Int,2001,59(4):1498-1509.
3Praga M,Hernandez E,Morales E,et al.Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis[J].Nephrol Dial Transplant,2001,16(9):1790-1798.
4Shankland S J.The podocyte's response to injury:role in proteinuria and glomerulosclerosis[J].Kidney Int,2006,69(12):2131-2147.
5Proctor G,Jiang T,Iwahashi M,et al.Regulation of renal fatty acid and cholesterol metabolism,inflammation,and fibrosis in Akita and OVE26 mice with type 1 diabetes[J].Diabetes,2006,55(9):2502-2509.
6Oscai L B,Miller W C,Arnall D A.Effects of dietary sugar and of dietary fat on food intake and body fat content in rats[J].Growth,1987,51(1):64-73.
7Attia D M,Ni Z N,Boer P,et al.Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats[J].Kidney Int,2002,61(5):1776-1787.
8Benzing T.Signaling at the slit diaphragm[J].J Am SocNephrol,2004,15(6):1382-1391.
9Aaltonen P,Luimula P,Astrom E,et al.Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy[J].Lab Invest,2001,81(9):1185-1190.
10Koop K,Eikmans M,Baelde H J,et al.Expression of podocyte-associated molecules in acquired human kidney diseases[J].J Am Soc Nephrol,2003,14(8):2063-2071.
